Zimmer Holdings, Inc. (NYSE:ZMH)

CAPS Rating: 4 out of 5

The Company designs, develops, manufactures and markets reconstructive orthopaedic implants, including joint and dental, spinal implants, trauma products and related orthopaedic surgical products.

Results 1 - 20 of 95 : 1 2 3 4 5 Next »

Recs

0
Member Avatar Dividends500 (84.32) Submitted: 5/16/2014 4:28:07 PM : Outperform Start Price: $94.28 ZMH Score: +2.50

Dividends500 tracks the 200 strongest dividends in the S&P 500. To qualify as a strong dividend, the company must meet two simple requirements:

- A payout ratio below 50%
- An increasing dividend from the prior year

Because there are more than 200 dividend paying companies in the S&P 500 that meet these requirements, the qualifying companies with the largest dividend yields were chosen.

Dividends500 intends to test this FactSet article, which highlights these strong dividend paying companies and their outperformance versus the S&P 500 as a whole (Page 12).

http://www.factset.com/websitefiles/PDFs/dividend/dividend_12.16.13

If you have questions or see something you think is inaccurate feel free to let me know.

Recs

0
Member Avatar Sicb (20.39) Submitted: 10/25/2013 4:00:18 PM : Outperform Start Price: $85.58 ZMH Score: +11.19

Zimmer Holdings, Inc. (Zimmer) designs, develops, manufactures and markets orthopaedic reconstructive, spinal and trauma devices, biologics, dental implants and related surgical products. The Company’s customers include orthopaedic surgeons, neurosurgeons, oral surgeons, dentists, hospitals, stocking distributors, healthcare dealers and, in their capacity as agents, healthcare purchasing organizations or buying groups. It manages its operations through three geographic segments: the Americas, which is consisted of the United States and includes other North, Central and South American markets; Europe, which is consisted of Europe and includes the Middle East and Africa markets, and Asia Pacific, which is consisted of Japan and Australia and includes other Asian and Pacific markets. In May 2013, Zimmer Holdings Inc acquired Knee Creations LLC. In June 2013, Zimmer Holdings Inc acquired NORMED Medizin Technik GmbH.

Recs

0
Member Avatar rossnr3 (49.25) Submitted: 6/6/2013 10:57:12 AM : Outperform Start Price: $76.26 ZMH Score: +16.56

Demographics will drive demand

Recs

0
Member Avatar Zakgirl (25.72) Submitted: 2/10/2013 6:33:55 PM : Outperform Start Price: $74.51 ZMH Score: +11.61

Liked that its name began with a Z.

Recs

0
Member Avatar Dennis99 (< 20) Submitted: 8/29/2011 9:39:02 PM : Outperform Start Price: $53.92 ZMH Score: +33.26

Baby boomer joints are failing; demand will persist.

Recs

0
Member Avatar TMFRisingStars (< 20) Submitted: 1/31/2011 8:50:55 AM : Outperform Start Price: $57.07 ZMH Score: +31.65

Here's the buy rec:
http://www.fool.com/investing/general/2011/01/28/rising-star-buy-zimmer-holdings.aspx?source=ihpsitota0000001&lidx=2

Recs

0
Member Avatar PIThompson (< 20) Submitted: 1/28/2011 5:30:19 PM : Outperform Start Price: $57.07 ZMH Score: +31.65

I think that joint and other replacement operations are going to grow even faster than most analysts expect. this is based on my experience with people near my age (66), what they are experiencing (close to or at needing such an operation) and the overwhelming desire to stay active.

Recs

0
Member Avatar taylor4u (66.51) Submitted: 11/10/2010 3:56:38 PM : Underperform Start Price: $50.23 ZMH Score: -49.88

Zimmer is seeing modest declines in business while peers (i.e. Stryker) see modest growth. They saw significant declines in Europe which represents a sizable part of their business. Additionally, the CEO seems to have more background in law than in business.

Recs

0
Member Avatar tekwatchlist (94.85) Submitted: 9/22/2010 3:51:52 PM : Outperform Start Price: $50.49 ZMH Score: +29.47

Added 8/23/10

Recs

0
Member Avatar tekennedy (74.43) Submitted: 8/24/2010 11:26:43 AM : Outperform Start Price: $48.79 ZMH Score: +34.51

A high ROE business with the ability to grow. Demographics should lead revenue to grow faster than market. Current pricing is attractive for longterm investors.

Recs

1
Member Avatar Greenesthorn (20.76) Submitted: 8/1/2010 4:13:24 PM : Underperform Start Price: $52.01 ZMH Score: -27.26

Concerned with news of hip replacement failures and attention from the US senate: http://topics.nytimes.com/topics/news/business/companies/zimmer_holdings/index.html

Recs

0
Member Avatar dbb032 (54.98) Submitted: 7/9/2010 2:38:08 PM : Outperform Start Price: $54.46 ZMH Score: +9.94

Good range of products. Marketing "Iffy".

Recs

0
Member Avatar twoshadows (84.22) Submitted: 6/28/2010 1:18:55 PM : Outperform Start Price: $53.23 ZMH Score: +14.85

The company has been and continues to be in a strong position. The need for quality prosthetics will on increase as long as the wars go on.

Recs

0
Member Avatar Survivn2 (20.66) Submitted: 5/26/2010 4:31:04 PM : Outperform Start Price: $53.43 ZMH Score: +16.86

PEG = 1.29, low risk = 10, gut

Recs

0
Member Avatar AQ1USN (67.19) Submitted: 5/3/2010 4:07:44 PM : Outperform Start Price: $58.23 ZMH Score: +11.59

With the troops coming back injured in need of prothsetics, the demand for these devices will only increase for the foreseeable future. Company has a history of good management.

Recs

0
Member Avatar pjani06 (29.09) Submitted: 2/11/2010 8:38:53 PM : Outperform Start Price: $55.50 ZMH Score: +5.23

medical related picks I would look to go long on:
ANIK, RTIX, PPDI, EXAC, ZMH

Recs

1
Member Avatar kevinottofro (97.93) Submitted: 7/19/2009 12:50:00 PM : Outperform Start Price: $40.68 ZMH Score: +51.50

Low relative PE, good star ranking, PEG & 09 PE still below normal - bottom fishing 7/20 picks.

Recs

0
Member Avatar pro2col (54.24) Submitted: 7/10/2009 3:49:49 PM : Outperform Start Price: $37.50 ZMH Score: +58.65

Once the recession is over and the government healthcare scare is eleviated.

Recs

0
Member Avatar picbois (98.92) Submitted: 3/28/2009 12:56:23 PM : Outperform Start Price: $36.16 ZMH Score: +42.74

Beaten down stock with an important edge in the prothesis market. The demographic trend will help in this case. However, must be always innovative and at the top of their league to keep strong relation to surgeons.

Recs

0
Member Avatar missterius1 (96.10) Submitted: 2/15/2009 8:47:21 PM : Outperform Start Price: $38.94 ZMH Score: +20.41

Think about it.......makes sense to me.

Results 1 - 20 of 95 : 1 2 3 4 5 Next »

Featured Broker Partners


Advertisement